Ipamorelin
Price range: $40.00 through $55.00
Ipamorelin is a synthetic pentapeptide that selectively stimulates the ghrelin receptor to promote natural, pulsatile growth hormone release in research models.
For research use only. Not for human or veterinary consumption.
Please note, to maintain the quality and integrity of every product, all orders are fulfilled on a made-to-order basis. Please allow 7–14 days for processing and delivery. You will receive tracking details as soon as your order is dispatched.
Research Use Only.
This compound is supplied strictly for in vitro research purposes. It is not approved by the FDA and is not intended for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing, you confirm you are a qualified researcher aged 18+.
- HPLC Verified
- COA Included
- For 21+ Only
- US Sourced
Ipamorelin is a synthetic pentapeptide that selectively stimulates the ghrelin receptor to promote natural, pulsatile growth hormone release in research models.
Key research areas
- Selective growth hormone release
- Ghrelin (GHS-R1a) receptor signalling
- Recovery and body-composition research
Product details
- Class: Selective ghrelin-receptor agonist (GHRP)
- Available sizes: 5 mg, 10 mg
- Form: Lyophilised powder
- Purity and identity: refer to the batch Certificate of Analysis (COA)
- Storage: store lyophilised product cold and protected from light; follow batch documentation
For research use only. Not for human or veterinary consumption. Not approved by the FDA for the uses described. This information is provided for educational and scientific reference only and is not medical advice.
| Weight | 1 lbs |
|---|---|
| Dimensions | 7 × 4 × 2 in |
| Size | 5 mg, 10 mg |
Lyophilized: Stable at −20°C for up to 24 months when kept dry and protected from light.
Reconstituted: Store at 2–8°C. Use within 28 days. Do not freeze after reconstitution.
Diluent: Bacteriostatic water (BW) recommended for multi-dose use. See Protocols.
You may also research
Related Compounds
Reviews
There are no reviews yet.